NASDAQ: LYCA · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Lycia Therapeutics Inc.

How Lycia Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.4B

Price

$27.73

52-week range

$27.73–$30.00

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources